4//SEC Filing
Carlucci Joseph A 4
Accession 0001140361-21-002176
CIK 0001498068other
Filed
Jan 25, 7:00 PM ET
Accepted
Jan 26, 5:38 PM ET
Size
14.9 KB
Accession
0001140361-21-002176
Insider Transaction Report
Form 4
Carlucci Joseph A
DirectorCEO
Transactions
- Disposition to Issuer
Common Stock
2021-01-25−590,879→ 0 total - Disposition to Issuer
Common Stock
2021-01-25−654,285→ 0 total(indirect: See Footnote) - Disposition to Issuer
Stock Option (Right to Buy)
2021-01-25−199,307→ 0 totalExercise: $6.47Exp: 2023-03-22→ Common Stock (199,307 underlying)
Footnotes (3)
- [F1]On January 25, 2021, pursuant to that certain Agreement and Plan of Merger, dated as of October 1, 2020 (the "Merger Agreement"), by and among the Issuer, IRC Superman Midco, LLC ("IRC") and Superman Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer with the Issuer surviving as a wholly owned subsidiary of IRC (the "Merger"). Upon consummation of the Merger (the "Effective Time"), each share of common stock of the Issuer was cancelled and converted into the right to receive $11.50 per share in cash (the "Per Share Merger Consideration"). In addition, each unvested share of restricted stock, including performance-based restricted stock, automatically vested and was converted in the right to receive the Per Share Merger Consideration.
- [F2]Shares held by trusts for the benefit of the Reporting Person's family. The Reporting Person disclaims beneficial ownership of the shares held by such trusts, except to the extent of the Reporting Person's pecuniary interest therein. The filing of this statement by the Reporting Person shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, such Reporting Person is the beneficial owner of the securities reported herein.
- [F3]Pursuant to the procedures set forth in the Merger Agreement, immediately prior to the Effective Time, each option vested in full and was cancelled in exchange for the right to receive an amount in cash equal to the product of (x) the total number of shares subject to the option multiplied by (y) the excess, if any, of the Per Share Merger Consideration over the exercise price per share under such option, less applicable withholding taxes. If the amount that could have been obtained upon the exercise of the option pursuant to the foregoing is equal to or less than zero, then the option was terminated without payment.
Documents
Issuer
American Renal Associates Holdings, Inc.
CIK 0001498068
Entity typeother
Related Parties
1- filerCIK 0001655251
Filing Metadata
- Form type
- 4
- Filed
- Jan 25, 7:00 PM ET
- Accepted
- Jan 26, 5:38 PM ET
- Size
- 14.9 KB